Browse by author
Lookup NU author(s): Professor Mike Waring,
Dr James Smith
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Two series of inhibitors of type III phosphatidylinositol-4-kinase were identified by high throughput screening and optimised to derive probe compounds that independently and selectively inhibit the α- and the β-isoforms with no significant activity towards related kinases in the pathway. In a cellular environment, inhibition of the α- but not the β-subtype led to a reduction in phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate concentration, causing inhibition of inositol-1-phosphate formation and inhibition of proliferation in a panel of cancer cell lines.
Author(s): Waring MJ, Andrews DM, Faulder PF, Flemington V, McKelvie JC, Maman S, Preston M, Raubo P, Robb GR, Roberts K, Rowlinson R, Smith JM, Swarbrick ME, Treines I, Winter JG, Wood RJ
Publication type: Article
Publication status: Published
Journal: Chemical Communications
Print publication date: 25/05/2014
Online publication date: 13/12/2013
Acceptance date: 12/12/2013
ISSN (print): 1359-7345
ISSN (electronic): 1364-548X
Publisher: Royal Society of Chemistry
PubMed id: 24366037
Notes: Invited article - part of themed collection: 2014 Emerging Investigators.
Altmetrics provided by Altmetric